John Wantania1, Ahsanuddin Attamimi2, Rukmono Siswishanto3. 1. Associate Professor, Department of Obstetric and Gynaecology, Maternal Foetal Medicine Division, Medical Faculty, Sam Ratulangi University, Manado, Indonesia. 2. Assistant Professor, Department of Obstetric and Gynaecology, Maternal Foetal Medicine Division, Medical Faculty, Gadjah Mada University, Yogyakarta, Indonesia. 3. Associate Professor, Department of Obstetric and Gynaecology, Maternal Foetal Medicine Division, Medical Faculty, Gadjah Mada University, Yogyakarta, Indonesia.
Abstract
INTRODUCTION: Preeclampsia is a pregnancy complication characterized by high blood pressure and proteinuria. Endothelial dysfunction is a major theory suggested as its aetiology. It is caused by anti-angiogenic condition characterized by low Vascular Endothelial Growth Factor (VEGF). An estradiol metabolite, called 2-Methoxy Estradiol (2-ME), is produced with the help of Catechol-O-Methyltransferase (COMT). This substance has an important role in VEGF expression. A 2-ME is suppressed in women with preeclampsia. AIM: To compare 2-ME in women with severe preeclampsia and normotensive pregnancy. MATERIALS AND METHODS: A total of 80 subjects qualified the inclusion and exclusion criteria, were divided into two groups (40 each): the severe preeclampsia and the normotensive pregnancy. Blood sample was collected and examined with the ELISA 2-ME kit (Cayman). The data were compared and calculated using Fisher-Exact test to examine 2-ME differences between the two groups. RESULTS: Women age, parity, and gestational age showed a non significant difference between both groups. Nonetheless, the BMI before pregnancy and the history of preeclampsia in the past pregnancy showed significant differences. In this study, the 2-ME value was lower in the severe preeclampsia group compared to the normotensive. CONCLUSION: This study concludes that 2-ME value in severe preeclampsia is lower than normotensive pregnancy. A lower 2-ME value may indicate COMT not producing enough 2-ME which in turn may cause the pre-eclampsia.
INTRODUCTION: Preeclampsia is a pregnancy complication characterized by high blood pressure and proteinuria. Endothelial dysfunction is a major theory suggested as its aetiology. It is caused by anti-angiogenic condition characterized by low Vascular Endothelial Growth Factor (VEGF). An estradiol metabolite, called 2-Methoxy Estradiol (2-ME), is produced with the help of Catechol-O-Methyltransferase (COMT). This substance has an important role in VEGF expression. A 2-ME is suppressed in women with preeclampsia. AIM: To compare 2-ME in women with severe preeclampsia and normotensive pregnancy. MATERIALS AND METHODS: A total of 80 subjects qualified the inclusion and exclusion criteria, were divided into two groups (40 each): the severe preeclampsia and the normotensive pregnancy. Blood sample was collected and examined with the ELISA 2-ME kit (Cayman). The data were compared and calculated using Fisher-Exact test to examine 2-ME differences between the two groups. RESULTS:Women age, parity, and gestational age showed a non significant difference between both groups. Nonetheless, the BMI before pregnancy and the history of preeclampsia in the past pregnancy showed significant differences. In this study, the 2-ME value was lower in the severe preeclampsia group compared to the normotensive. CONCLUSION: This study concludes that 2-ME value in severe preeclampsia is lower than normotensive pregnancy. A lower 2-ME value may indicate COMT not producing enough 2-ME which in turn may cause the pre-eclampsia.
Entities:
Keywords:
Body mass index; Estradiol metabolite; Preeclampsia
Authors: Lori D Hill; Timothy P York; Juan P Kusanovic; Ricardo Gomez; Lindon J Eaves; Roberto Romero; Jerome F Strauss Journal: PLoS One Date: 2011-01-31 Impact factor: 3.240
Authors: L T Roten; M H Fenstad; S Forsmo; M P Johnson; E K Moses; R Austgulen; F Skorpen Journal: Mol Hum Reprod Date: 2011-02-25 Impact factor: 4.025
Authors: Darios Getahun; Cande V Ananth; Yinka Oyelese; Martin R Chavez; Russell S Kirby; John C Smulian Journal: Obstet Gynecol Date: 2007-12 Impact factor: 7.623
Authors: Jacqueline G Parchem; Keizo Kanasaki; Megumi Kanasaki; Hikaru Sugimoto; Liang Xie; Yuki Hamano; Soo Bong Lee; Vincent H Gattone; Samuel Parry; Jerome F Strauss; Vesna D Garovic; Thomas F McElrath; Karen H Lu; Baha M Sibai; Valerie S LeBleu; Peter Carmeliet; Raghu Kalluri Journal: J Clin Invest Date: 2018-10-08 Impact factor: 14.808